Jie D'Elia

Executive Director, Business Development Transactions at Bristol-Myers Squibb

Jie D’Elia is the Executive Director, Business Development Transactions at Bristol-Myers Squibb. In this role, Jie serves as the global lead in negotiating business development and licensing transactions.

 

Prior to joining Bristol-Myers Squibb in 2013, Jie served as the Corporate Vice President and Global Head of Business Development at Simcere Pharmaceutical, a fast growing leading Chinese pharmaceutical company with presence in North America and Europe. While at Simcere, she led the conceptualization and negotiation of a series of first-in-kind, high impact strategic partnerships, including a joint venture between Simcere and Merck Sharp & Dohme. Prior to joining Simcere, Jie worked at AstraZeneca and the Boston Consulting Group.

 

Jie holds a Ph.D. in Pharmacy from the University of Texas at Austin and an M.B.A from Columbia Business School.

Alle sessies door Jie D'Elia

Educational Panel

di, 12 feb 2019 4 p.m. - 5 p.m.
Shubert Complex - 6th Floor